[1]袁子薇,张 哲,袁伟杰,等.晚期糖基化终末产物、氧化应激在急性脑梗死患者中的临床意义[J].医学信息,2022,35(06):90-92.[doi:10.3969/j.issn.1006-1959.2022.06.022]
　YUAN Zi-wei,ZHANG Zhe,YUAN Wei-jie,et al.Clinical Significance of Advanced Glycation End Products and Oxidative Stress in Patients with Acute Cerebral Infarction[J].Medical Information,2022,35(06):90-92.[doi:10.3969/j.issn.1006-1959.2022.06.022]
点击复制

晚期糖基化终末产物、氧化应激在急性脑梗死患者中的临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年06期
页码:
90-92
栏目:
论著
出版日期:
2022-03-15

文章信息/Info

Title:
Clinical Significance of Advanced Glycation End Products and Oxidative Stress in Patients with Acute Cerebral Infarction
文章编号:
1006-1959（2022）06-0090-03
作者:
袁子薇; 张 哲; 袁伟杰; 等
（1.河北省中医院脑病科，河北 石家庄 050000；2.石家庄市第三医院创伤三科，河北 石家庄 050000）
Author(s):
YUAN Zi-wei; ZHANG Zhe; YUAN Wei-jie; et al.
(1.Department of Encephalopathy,Hebei Hospital of Traditional Chinese Medicine,Shijiazhuang 050000,Hebei,China;2.The third Department of Trauma,Shijiazhuang Third Hospital,Shijiazhuang 050000,Hebei,China)
关键词:
急性脑梗死; 晚期糖基化终末产物; 丙二醛; 超氧化物歧化酶; 总抗氧化能力
Keywords:
Acute cerebral infarction; Advanced glycation end products; Malondialdehyde; Superoxide dismutase; Total antioxidant capacity
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2022.06.022
文献标志码:
A
摘要:
目的 分析晚期糖基化终末产物（AGEs）、氧化应激指标在急性脑梗死患者中的临床意义。方法 选取2018年1月-2019年12月河北省中医院脑病科收治的急性脑梗死患者56例作为急性脑梗死组，另选取同期本院健康体检者30例作为对照组，比较两组AGEs及氧化应激指标[丙二醛（MDA）、超氧化物歧化酶（SOD）和总抗氧化能力（T-AOC）]及急性脑梗死组中不同NIHSS评分患者AGEs及氧化应激指标，并采用Pearson相关性分析急性脑梗死患者AGEs与NIHSS评分、MDA、SOD、T-AOC的关系。结果 急性脑梗死组AGEs、MDA水平高于对照组，SOD、T-AOC水平低于对照组，差异有统计学意义（P＜0.05）；NIHSS≥4分者AGEs、MDA水平高于NIHSS＜4分者，SOD、T-AOC水平低于NIHSS＜4分者，差异有统计学意义（P＜0.05）；Pearson相关性分析显示，急性脑梗死患者AGEs与NIHSS评分、MDA呈正相关（r=0.326、0.328，P＜0.05），与SOD、T-AOC呈负相关（r=-0.297、-0.267，P＜0.05）。结论 急性脑梗死严重程度与AGEs、氧化应激密切相关，AGEs可能是急性脑梗死患者危险因素。
Abstract:
Objective To investigate the clinical significance of advanced glycation end products (AGEs) and oxidate stress in patients with acute cerebral infarction.Methods A total of 56 patients with acute cerebral infarction admitted to the Department of Encephalopathy of Hebei Hospital of Traditional Chinese Medicine from January 2018 to December 2019 were selected as acute cerebral infarction group, and 30 healthy subjects in our hospital during the same period were selected as control group. AGEs and oxidative stress indexes [malondialdehyde (MDA), superoxide dismutase (SOD) and total antioxidant capacity (T-AOC)] and AGEs and oxidative stress indexes of patients with different NIHSS scores in the two groups were compared, and Pearson correlation was used to analyze the relationship between AGEs and NIHSS scores, MDA, SOD and T-AOC in patients with acute cerebral infarction.Results The levels of AGEs and MDA in the acute cerebral infarction group were higher than those in the control group, and the levels of SOD and T-AOC were lower than those in the control group, the difference was statistically significant (P<0.05). The levels of AGEs and MDA in patients with NIHSS≥4 scores were higher than those in patients with NIHSS<4 scores, and the levels of SOD and T-AOC were lower than those in patients with NIHSS<4 scores, the difference was statistically significant (P<0.05). Pearson correlation analysis showed that AGEs in patients with acute cerebral infarction were positively correlated with NIHSS score and MDA (r=0.326, 0.328, P<0.05), and negatively correlated with SOD and T-AOC (r=-0.297, -0.267, P<0.05).Conclusion The severity of acute cerebral infarction is closely related to AGEs and oxidative stress. AGEs may be a risk factor for acute cerebral infarction.

参考文献/References:

[1]王维铁,张旭,许日昊,等.冠心病患者冠状动脉病变程度与颈动脉粥样硬化及脑梗死的关系[J].中国动脉硬化杂志,2017,25(2):171-174.[2]Maciejczyk M,ebrowska E,Chabowski A.Insulin resistance and oxidative stress in the brain: what’s new?[J].Int J Mol Sci,2019,20(4):874.[3]Prasad K,Tiwari S.Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease[J].Curr Pharm Des,2017,23(6):937-943.[4]Byun K,Yoo YC,Son M,et al.Advanced glycation end-products produced systemically and by macrophages:A common contributor to inflammation and de generative diseases[J]. Pharmacol Ther,2017,13(177):44-55.[5]Ohnuki Y,Nagano R,Takizawa S,et al.Advanced glycation end products in patients with cerebral infarction[J].Intern Med,2009,48(8):587-591.[6]Adamopoulos C,Piperi C,Gargalionis AN,et al.Advanced glycation end products upregulatelysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways[J].Cell Mol Life Sci,2016,73(8):1685-1698. [7]李瑾,白瑞,秦卫伟,等.晚期糖基化终产物对心肌细胞葡萄糖转运蛋白1表达的影响及机制研究[J].中国药物与临床,2018,18(4):512-514.[8]Yamagishi SI,Matsui T,Ishibashi Y,et al.Phytochemicals Against Advanced Glycation End Products (AGEs)and the Receptor System[J].Curr Pharm Des,2017,23(8):1135-1141. [9]Xu J,Chen LJ,Yu J,et al.Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy[J].Cell Physiol Biochem,2018,48(2):705-717. [10]Petrea RE,Beiser AS,Seshadri S,et al.Gender differences in stroke incidence and poststroke disability in the Framingham heart study[J].Stroke,2009(40):1032-1037.[11]Koska J,Saremi A,Howell S,et al.Advanced Glycation End Products,Oxidation Products,and Incident Cardiovascular Events in Patients With Type 2 Diabetes[J].Diabetes Care,2018,41(3):570-576. [12]Fischer CC.Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension[J].Int J Angiol,2017,26(1):2-11. [13]Tang D,Chen X,Kang R,et al.Ferroptosis: molecular mechanisms and health implications[J].Cell Res,2021,31(2):107-125.[14]Shah D,Aggarwal A,Bhatnagar A,et al.Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus[J].Free Radic Res,2011,45(5):559-567.[15]Jiang WX,Wang RS,Liu D,et al.Protective Effects of Kaempferitrin on Advanced Glycation End Products Induce Mesangial Cell Apoptosis and Oxidative Stress[J].Int J Mol Sci,2018,19(11):3334. [16]Grochowski C,Litak J,Kamieniak P,et al.Oxidative stress in cerebral small vessel disease. Role of reactive species[J].Free Radic Res,2018,52(1):1-13.[17]Bhat SA,Sood A,Shukla R,et al.AT2R Activation prevents microglia pro-inflammatory activation in a NOX-dependent manner: inhibition of PKC activation and p47phox phosphorylation by PP2A[J].Mol Neurobiol,2019,56(4):3005-3023. [18]Nissanka N,Moraes CT.Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease[J].FEBS Lett,2018,592(5):728-742.

相似文献/References:

[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
　FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Medical Information,2018,31(06):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
　CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Medical Information,2018,31(06):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[3]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
　LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Medical Information,2018,31(06):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[4]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Medical Information,2019,32(06):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[5]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
　ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Medical Information,2019,32(06):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
[6]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的 疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
　TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Medical Information,2019,32(06):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[7]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Medical Information,2019,32(06):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
[8]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
　WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Medical Information,2019,32(06):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[9]陈 曦,刘 楠,张洪淞.尤瑞克林治疗急性脑梗死患者的临床效果[J].医学信息,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
　CHEN Xi,LIU Nan,ZHANG Hong-song.Clinical Effect of Ureklin in Patients with Acute Cerebral Infarction[J].Medical Information,2019,32(06):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
[10]陈 曦,刘 楠,张洪淞.马来酸桂哌齐特联合尤瑞克林在急性脑梗死患者中的疗效[J].医学信息,2019,32(14):142.[doi:10.3969/j.issn.1006-1959.2019.14.046]
　CHEN Xi,LIU Nan,ZHANG Hong-song.Efficacy of Cinepazide Maleate Combined with Uricillin in Patients with Acute Cerebral Infarction[J].Medical Information,2019,32(06):142.[doi:10.3969/j.issn.1006-1959.2019.14.046]

更新日期/Last Update: 1900-01-01